Published in J Cell Biol on April 01, 1988
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A (1993) 2.86
Expression of extracellular matrix components is regulated by substratum. J Cell Biol (1990) 2.68
Inspiration and application in the evolution of biomaterials. Nature (2009) 2.23
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17
Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest (2008) 2.15
Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol (1990) 2.09
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol (1990) 2.00
Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest (1990) 1.84
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol (1992) 1.72
Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol (2005) 1.60
TGF-beta: problems and prospects. Cell Regul (1990) 1.59
Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci U S A (2005) 1.59
Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol (2001) 1.52
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol (2006) 1.50
Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol (1988) 1.49
Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis (2015) 1.49
VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci U S A (2006) 1.40
Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest (1996) 1.38
Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34
Geometrically controlled endothelial tubulogenesis in micropatterned gels. Tissue Eng Part A (2010) 1.33
COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet (2012) 1.26
Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest (1994) 1.24
Improved throughput traction microscopy reveals pivotal role for matrix stiffness in fibroblast contractility and TGF-β responsiveness. Am J Physiol Lung Cell Mol Physiol (2012) 1.22
The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol (2014) 1.22
Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res (2001) 1.21
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol (1993) 1.19
Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol (2009) 1.19
Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol (1989) 1.18
Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol (2007) 1.16
Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med (1994) 1.14
Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol (1997) 1.13
High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol (1990) 1.11
Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci U S A (1996) 1.11
Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J Clin Invest (1992) 1.10
Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. Am J Pathol (1991) 1.09
Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance. Am J Pathol (1990) 1.07
Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol (1997) 1.07
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. BMC Cell Biol (2006) 1.05
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. J Clin Invest (1991) 1.02
Loss of endothelial furin leads to cardiac malformation and early postnatal death. Mol Cell Biol (2012) 1.00
Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1. J Clin Invest (1992) 1.00
Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis (2008) 1.00
Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer (1999) 0.98
TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study. BMC Cancer (2007) 0.98
Atherosclerosis- and age-related multinucleated variant endothelial cells in primary culture from human aorta. Am J Pathol (1989) 0.97
Natural product inhibitors of ocular angiogenesis. Exp Eye Res (2014) 0.97
Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol (1995) 0.96
Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation. J Clin Invest (1996) 0.95
Hypoxia induces endothelial cell synthesis of membrane-associated proteins. Proc Natl Acad Sci U S A (1991) 0.94
Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. BMC Cancer (2006) 0.93
Neovascularization in aged mice: delayed angiogenesis is coincident with decreased levels of transforming growth factor beta1 and type I collagen. Am J Pathol (1998) 0.92
TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α. Mol Cancer Res (2012) 0.90
YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment. Oncotarget (2015) 0.90
Aqueous humor TGF-β2 levels in patients with open-angle glaucoma: A meta-analysis. Mol Vis (2015) 0.87
VEGF-A and Semaphorin3A: modulators of vascular sympathetic innervation. Dev Biol (2009) 0.86
Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann Surg (1990) 0.85
Influence of argon laser trabeculoplasty on transforming growth factor-beta 2 concentration and bleb scarring following trabeculectomy. Graefes Arch Clin Exp Ophthalmol (2003) 0.85
A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways. Mol Biol Cell (1993) 0.84
Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1. Am J Pathol (1992) 0.84
Hyaluronan-binding protein in endothelial cell morphogenesis. J Cell Biol (1992) 0.82
TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling. J Cell Biochem (2008) 0.82
Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion. Am J Pathol (1992) 0.80
Modulation of fibronectin production in normal human melanocytes and malignant melanoma cells by interferon-gamma and tumor necrosis factor-alpha. Am J Pathol (1989) 0.78
Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J Biol Chem (2013) 0.77
Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro. Am J Pathol (1993) 0.77
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines. J Cancer Res Clin Oncol (2012) 0.77
AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton. Angiogenesis (2015) 0.76
A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway. Lab Invest (2015) 0.75
Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. J Clin Invest (1991) 0.75
In Vitro Multitissue Interface Model Supports Rapid Vasculogenesis and Mechanistic Study of Vascularization across Tissue Compartments. ACS Appl Mater Interfaces (2016) 0.75
Capturing extracellular matrix properties in vitro: Microengineering materials to decipher cell and tissue level processes. Exp Biol Med (Maywood) (2016) 0.75
Transforming Growth Factor-beta: A Therapeutic Target for Cancer. Hum Vaccin Immunother (2017) 0.75
A simple, rapid, and sensitive DNA assay procedure. Anal Biochem (1980) 23.88
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08
Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77
Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol (1983) 3.60
The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell (1987) 3.52
A-CAM: a 135-kD receptor of intercellular adherens junctions. I. Immunoelectron microscopic localization and biochemical studies. J Cell Biol (1986) 2.98
A-CAM: a 135-kD receptor of intercellular adherens junctions. II. Antibody-mediated modulation of junction formation. J Cell Biol (1986) 2.94
In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol (1983) 2.91
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science (1986) 2.67
Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A (1987) 2.50
Ultrastructural localization of fibronectin and laminin in the basement membranes of the murine kidney. J Cell Biol (1980) 2.42
Organizational behavior of human umbilical vein endothelial cells. J Cell Biol (1982) 2.15
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol (1987) 2.04
Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol (1987) 1.93
Purification and characterization of heparin-binding endothelial cell growth factors. J Biol Chem (1986) 1.89
Fibronectin-associated transforming growth factor. J Cell Physiol (1987) 1.89
Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol (1980) 1.89
Epidermal cells adhere preferentially to type IV (basement membrane) collagen. J Cell Biol (1979) 1.86
Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun (1986) 1.86
Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab Invest (1986) 1.78
Endothelial cell-matrix interactions: in vitro models of angiogenesis. J Histochem Cytochem (1986) 1.49
Mechanisms of cytoskeletal regulation: modulation of aortic endothelial cell protein band 4.1 by the extracellular matrix. J Cell Physiol (1986) 1.37
Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest (1986) 1.36
Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem (1987) 1.30
The microvascular extracellular matrix. Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol (1987) 1.23
Interactions of vascular wall cells with collagen gels. Lab Invest (1982) 1.20
Use of avidin-biotin complex in an ELISA system: a quantitative comparison with two other immunoperoxidase detection systems using keratin antisera. Lab Invest (1983) 1.18
Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol (1982) 1.16
Endothelial cell-matrix interactions in hemostasis. Prog Hemost Thromb (1982) 1.10
Endothelial cell-extracellular matrix interactions. Ann N Y Acad Sci (1985) 1.04
Components of subendothelial aorta basement membrane. Immunohistochemical localization and role in cell attachment. Lab Invest (1983) 1.03
Growth in primary culture of mouse submandibular epithelial cells embedded in collagen gels. In Vitro (1982) 0.99
Aortic endothelial cell proteoheparan sulfate. II. Modulation by extracellular matrix. Am J Pathol (1987) 0.81
Taking health status into account when setting capitation rates: a comparison of risk-adjustment methods. JAMA (1996) 2.78
Patients' attitudes to the provision of medical care from a health centre. J R Coll Gen Pract (1974) 2.14
The development of a risk-adjusted capitation payment system: the Maryland Medicaid model. J Ambul Care Manage (1998) 1.86
Transformation of Rickettsia prowazekii to rifampin resistance. J Bacteriol (1998) 1.85
Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab Invest (1986) 1.78
Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol (1988) 1.49
Endothelial cell-matrix interactions: in vitro models of angiogenesis. J Histochem Cytochem (1986) 1.49
Transformation of Rickettsia prowazekii to erythromycin resistance encoded by the Escherichia coli ereB gene. J Bacteriol (2000) 1.38
Mechanisms of cytoskeletal regulation: modulation of aortic endothelial cell protein band 4.1 by the extracellular matrix. J Cell Physiol (1986) 1.37
Mechanisms of cytoskeletal regulation. Modulation of aortic endothelial cell spectrin by the extracellular matrix. Am J Pathol (1984) 1.33
Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem (1987) 1.30
Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav (2009) 1.29
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood (2000) 1.15
An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. J Pharmacol Exp Ther (2012) 1.13
Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2. Kidney Int (2000) 1.09
Immunolocalization of type IV collagen and laminin in nonbasement membrane structures of murine corneal stroma. A light and electron microscopic study. Lab Invest (1985) 1.05
Endothelial cell-extracellular matrix interactions. Ann N Y Acad Sci (1985) 1.04
Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine (2012) 1.03
Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology (1991) 0.92
Realizing the potential of practice pattern profiling. Inquiry (1992) 0.90
The ultrastructural organization and architecture of basement membranes. Ciba Found Symp (1984) 0.90
Effects of nasal ZnSO4 irrigation and olfactory bulbectomy on rat pups. Physiol Behav (1976) 0.87
Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey. J Clin Endocrinol Metab (1992) 0.86
Interactions of vascular cells with transforming growth factors-beta. Ann N Y Acad Sci (1990) 0.86
Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum Gene Ther (1994) 0.85
The in vivo and in vitro effects of clomiphene citrate on ovulation, fertilization, and development of cultured mouse oocytes. Am J Obstet Gynecol (1983) 0.84
Acute and chronic renal effects of recombinant human TGF-beta2 in the rat. J Am Soc Nephrol (1999) 0.84
A study of ultrasound-induced microstreaming in blood vessels of tropical fish. Br J Cancer Suppl (1982) 0.83
Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1. Am J Pathol (1996) 0.83
Differential dysmorphogenesis induced by microinjection of an alkylating agent into rat conceptuses cultured in vitro. Teratology (1985) 0.82
Aortic endothelial cell proteoheparan sulfate. II. Modulation by extracellular matrix. Am J Pathol (1987) 0.81
Smokeless tobacco, reaction time, and strength in athletes. Med Sci Sports Exerc (1998) 0.80
Differences in the biological activities of transforming growth factor-beta and platelet-derived growth factor in vivo. Growth Factors (1991) 0.80
Characteristics of amino acid accumulation by isolated intestinal epithelial cells. J Membr Biol (1973) 0.77
Inhibition of connective tissue formation in dermal wounds covered with synthetic, moisture vapor-permeable dressings and its reversal by transforming growth factor-beta. J Invest Dermatol (1990) 0.77
Transforming growth factors-beta 1 and beta 2 enhance connective tissue formation in animal models of dermal wound healing by secondary intent. Ann N Y Acad Sci (1990) 0.76
The role of the accessory and main olfactory systems in maternal behavior of the primiparous rat. Behav Neural Biol (1984) 0.76
Transforming growth factors-beta 1 and beta 2 induce synthesis and accumulation of hyaluronate and chondroitin sulfate in vivo. Growth Factors (1990) 0.76
Site of gene action of the white allele (Miwh) of the microphthalmia locus: a dermal-epidermal recombination study. J Exp Zool (1982) 0.76
Pneumothorax in sports: issues in recognition and follow-up care. Phys Sportsmed (2000) 0.76
Observations of ultrasound-induced effects in the fish Xiphophorous maculatus. Ultrasound Med Biol (1983) 0.76
Concussion in sports. Am Fam Physician (1999) 0.75
Effects of microphthalmic white (Miwh) on the number and function of cutaneous melanocytes. J Exp Zool (1983) 0.75
Procedure for sectioning the brains of small animals In situ. Psychol Rep (1971) 0.75
Blonde, a new mutation in Peromyscus maniculatus affecting fur, skin, and eye pigmentation. J Hered (1982) 0.75
Self-assessment of hearing impairment: test of the expanded hearing ability scale questionnaire on hearing impaired adults in England. Br J Audiol (1977) 0.75
Disenrollment patterns in Medicare HMOs: a preliminary analysis. GHAA J (1988) 0.75
Pharmacy benefits in health maintenance organizations. Health Aff (Millwood) (1989) 0.75
Effects of telencephalic lesions on the gill cover response of Siamese fighting fish. Physiol Behav (1974) 0.75
Sampling technique for estimating roundworm burdens of sheep and cattle. Exp Parasitol (1971) 0.75